The stimulants Ritalin and Adderall have been used to treat attention-deficit/hyperactivity disorder (ADHD) for decades, but ...
The delayed sleep-wake phase in adolescents often overlaps with ADHD and restless legs syndrome, worsening insomnia and ...
Now, researchers say the stimulants don’t work as previously believed. Instead of affecting regions of the brain that control ...
Granules India Ltd on Thursday said its arm Granules Pharmaceuticals, Inc has received tentative approval from the US health ...
A new study suggests that common medications prescribed to help manage ADHD, such as Adderall and Ritalin, may work ...
A new study suggests that common medications prescribed to help manage ADHD, such as Adderall and Ritalin, may work ...
4d
Ark Biopharmaceutical Receives China Marketing Authorization for Aizhida for the Treatment of ADHD
Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that China's National Medical Products Administration ...
Granules India receives USFDA tentative approval for generic amphetamine extended-release tablets for ADHD treatment.
After evaluating scans of almost 5,800 children with and without attention deficit disorder, US researchers discovered that ...
German CNS-focused specialist Neuraxpharm Group announced the launches in Europe of Tuzulby (methylphenidate hydrochloride) prolonged-release chewable tablets and Paxneury (guanfacine) ...
Attention-deficit/hyperactivity disorder (ADHD) affects 3%–5% of children and about 2.5% of adults, though prevalence varies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback